Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02008526 · ClinicalTrials.gov registry record · NA
Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM
A NA study, sponsored by Friends Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 286
- Enrollment target
NCT02008526: Completed NA study, sponsored by Friends Research Institute.
NCT02008526 is a NA study that has completed, run by Friends Research Institute. The registered enrollment target is 286 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02008526, a NA study, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 286 participants
- Enrollment target
Study Summary
Participants receive culturally relevant and specifically tailored text messages based on the behavioral change theoretical constructs of Social Support Theory, Health Belief Model, and Social Cognitive Theory. Participants are randomized into one of three conditions for an 8-week intervention period: Group 1: culturally relevant theory-based text messages interactively transmitted by peer health educators (TXT-PHE); or, Group 2: the same culturally relevant theory-based text messages transmitted by automation (TXT-Auto); or, Group 3: assessment-only (AO) control with no theoretically based text messages.
Primary Outcome
Self-reported and/or biomarker-confirmed methamphetamine use assessed at baseline and 9-month follow-up assessment.
Interventions
- BEHAVIORAL Text Messages Transmitted by Peer Health Educators (TXT-PHE)
- BEHAVIORAL Text Messages Transmitted by Automation (TXT-Auto)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 286 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT02008526 record still lists
NCT02008526 is an interventional study that assigns participants to a tested intervention. The registered 286 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which Text Messages Transmitted by Peer Health Educators (TXT-PHE) is the first listed.
NCT02008526 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02008526 about?
NCT02008526 is a clinical study titled "Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM". Participants receive culturally relevant and specifically tailored text messages based on the behavioral change theoretical constructs of Social Support Theory, Health Belief Model, and Social Cognitive Theory. Participants are randomized into one of three conditions for an 8-week intervention perio...
What is the current status of trial NCT02008526?
This trial is currently completed. It is a NA study. The enrollment target is 286 participants. The study started on 2014-01. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02008526?
The interventions under investigation include: Text Messages Transmitted by Peer Health Educators (TXT-PHE) (BEHAVIORAL), Text Messages Transmitted by Automation (TXT-Auto) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02008526?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02008526's enrollment target sits among peer trials
286 377th of 2000 higher than 1,624 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04781140 · 286 participants · Phase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- NCT04936529 · 286 participants · Phase 2
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- NCT05183646 · 286 participants · Phase 3
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- NCT05506878 · 286 participants · NA
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia